Barclays raised the firm’s price target on Illumina (ILMN) to $122 from $110 and keeps an Underweight rating on the shares. The company reported a big instrument upside surprise in Q1, which bulls will point to, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN: